Cationic polymers that enhance the performance of HbsAg DNA in vivo

Vaccine

Volumn 23, Issue 4, 2004, Pages 460-469

  Bos, Gert W ^a,c   Kanellos, Theofanis ^b   Crommelin, Daan J A ^a,c   Hennink, Wim E ^a   Howard, Colin R ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c OctoPlus NV   (Netherlands)

Author keywords

Gene delivery; Hepatitis; Non viral; Polymeric transfectants

Indexed keywords

BETA GALACTOSIDASE; DNA VACCINE; HEPATITIS B SURFACE ANTIGEN; POLY[2 (DIMETHYLAMINO)ETHYL METHACRYLATE]; POLY[2 (DIMETHYLAMINO)ETHYLMETHACRYLATE CO METHACRYLIC ACID]; POLY[2 (TRIMETHYLAMINO)ETHYLMETHACRYLATE]; POLY[2 METHYLACRYLIC ACID 2 [(DIMETHYLAMINOETHYL)METHYLAMINO]ETHYL ESTER]; POLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELLULAR IMMUNITY; COMPLEX FORMATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; IMMUNE RESPONSE; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; GENE EXPRESSION; GENES, REPORTER; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; POLYMERS; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSFECTION; VACCINES, DNA;

EID: 7744234296     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.06.020     Document Type: Article

References (43)

1. H.L. Robinson DNA vaccines: basic mechanism and immune responses Int. J. Mol. Med. 4 1999 549 555
2. N.J. Mabjeesh, H. Zhong, and J.W. Simons Gene therapy of prostate cancer: current and future directions Endocr. Relat. Cancer. 9 2002 115 139
3. R. Tuteja DNA vaccine against malaria: a long way to go Crit. Rev. Biochem. Mol. Biol. 37 2002 29 54
4. A.M. Krieg CpG motifs in bacterial DNA and their immune effects Annu. Rev. Immunol. 20 2002 709 760
5. E.R. Kandimalla, L. Bhagat, Y. Cong, P. Pandey, R.K. Yu, and D. Zhao Secondary structures in CpG oligonucleotides affect immunostimulatory activity Biochem. Biophys. Res. Commun. 306 2003 948 953
6. F.D. Ledley Pharmaceutical approach to somatic gene therapy Pharm. Res. 13 1997 1595 1614
7. M.D. Brown, A.G. Schatzlein, and I.F. Uchegbu Gene delivery with synthetic (non-viral) carriers Int. J. Pharm. 229 2001 1 21
8. W.T. Godbey, and A.G. Mikos Recent progress in gene delivery using non-viral transfer complexes J. Control Release. 72 2001 115 125
9. S.C. De Smedt, J. Demeester, and W.E. Hennink Cationic polymer based gene delivery systems Pharm. Res. 17 2000 113 126
10. T. Merdan, J. Kopecek, and T. Kissel Prospects for cationic polymers in gene and oligonucleotide therapy against cancer Adv. Drug Del. Rev. 54 2002 715 758
11. L. Hanlon, and D.J. Argyle The science of DNA vaccination Infect. Dis. Rev. 3 2001 2
12. D.T. Curiel, E. Wagner, M. Cotton, M.L. Birnstiel, S. Agarwal, and C.M. Li High-efficiency gene transfer mediated by adenovirus coupled to DNA-complexes Hum. Gene Ther. 3 1992 147 154
13. O. Boussif, F. Lezoualc'h, M.A. Zanta, M.D. Mergny, D. Scherman, and B. Demeneix A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethyleneimine Proc. Natl. Acad. Sci. U.S.A. 92 1995 7297 7301
14. J.Y. Cherng, P. Van de Wetering, H. Talsma, D.J.A. Crommelin, and W.E. Hennink Effect of size and serum proteins on transfection efficiency of poly((2-dimethylamino) ethyl methacrylate)-plasmid nanoparticles Pharm. Res. 13 1996 1038 1042
15. P. Van de Wetering, N.M. Schuurmans-Nieuwenbroek, M.J. Van Steenbergen, D.J.A. Crommelin, and W.E. Hennink Copolymers of 2-(dimethylamino)ethyl methacrylate with ethoxytriethylene glycol methacrylate or N-vinyl-pyrrolidone as gene transfer agents J. Control Release 64 2000 193 203
16. C. Arigita, N.J. Zuidam, D.J.A. Crommelin, and W.E. Hennink Association and dissociation of polymer/DNA complexes used for gene delivery Pharm. Res. 16 1999 1534 1541
17. N.J. Zuidam, G. Posthuma, E.T. de Vries, D.J.A. Crommelin, W.E. Hennink, and G. Storm Effects of physicochemical characteristics of poly(2- (dimethylamino)ethyl methacrylate)-based polyplexes on cellular association and internalisation J. Drug Target 8 2000 51 66
18. F.J. Verbaan, C. Oussoren, I.M. Van Dam, Y. Takakura, M. Hashida, and D.J.A. Crommelin The fate of poly(2-dimethyl amino ethyl)-methacrylate-based polyplexes after intravenous administration Int. J. Pharm. 214 2001 99 101
19. A. Caputo, M. Betti, G. Altavilla, A. Bonaccorsi, C. Boarini, and M. Marchisio Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application Vaccine 20 2002 2303 2317
20. A. Caputo, R. Gavioli, G. Altavilla, E. Brocca-Cofano, C. Boarini, and M. Betti Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against Tat. Vaccine 21 2003 1103 1111
21. A.M. Funhoff, C.F. Van Nostrum, G.A. Koning, N.M.E. Schuurmans- Nieuwenbroek, D.J.A. Crommelin, and W.E. Hennink Endosomal escape of polymeric gene delivery complexes is not always enhanced by polymers buffering at low pH Biomacromolecules 5 2004 32 39
22. J.D. Rich, C.G. Ching, M.A. Lally, M.M. Gaitanis, B. Schwartzapfel, and A. Charuvastra A review of the case for hepatitis B vaccination of high-risk adults Am. J. Med. 114 2003 316 318
23. R. Schirmbeck, J. Wild, D. Stober, H.E. Blum, F.V. Chisari, and M. Geissler Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen J. Immunol. 164 2000 4235 4243
24. D.L. Elbert, and J.A. Hubbell Self-assembly and steric stabilization at heterogeneous, biological surfaces using adsorbing block copolymers Chem. Biol. 5 1998 177 183
25. A. Bout, D. Valerio, and B.J. Scholte In vivo transfer and expression of the LacZ gene in the mouse lung Exp. Lung Res. 19 1993 193 202
26. J.Y. Cherng, H. Talsma, R. Verrijk, D.J.A. Crommelin, and W.E. Hennink The effect of formulation parameters on the size of poly-((2-dimethylamino)ethyl methacrylate)-plasmid complexes Eur. J. Pharm. Biopharm. 47 1999 215 224
27. R. Finsy Particle sizing by quasi-elastic light scattering Adv. Colloid Interface Sci. 52 1994 79 143
28. A. Vecchione, B. Catchpole, F. D'Mello, T. Kanellos, and A. Hamblin Modulating immune responses with dendritic cells: an attainable goal in veterinary medicine? Vet. Immunobiol. Immunopathol. 87 2002 215 221
29. P. Russell, T. Kanellos, I. Sylvester, K. Chang, and C. Howard Nucleic acid immunisation with a reporter gene results in antibody production in goldfish (Carassius auratus L.) Fish Shellfish Immunol. 8 1998 121 128
30. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular Cloning, a laboratory manual 2nd ed. 1989 Cold Spring Harbor Laboratory Press New York, USA
31. P.K. Smith, R. Krohn, G. Hermanson, A. Mallia, F. Gartner, and E. Provenzano Measurement of protein using bicinchoninic acid Anal. Biochem. 150 1985 76 85
32. P. Van de Wetering, E.E. Moret, N.M.E. Schuurmans-Nieuwenbroek, M.J. Van Steenbergen, and W.E. Hennink Structure-activity relationships of water-soluble cationic methacrylate/methacrylamide polymers for nonviral gene delivery Bioconjugate Chem. 10 1999 687 692
33. A. Von Harpe, H. Petersen, Y.X. Li, and T. Kissel Characterization of commercially available and synthesized polyethylenimines for gene delivery J. Control Release 69 2000 309 322
34. P. Van de Wetering, J.Y. Cherng, H. Talsma, and W.E. Hennink Relation between transfection efficiency and cytotoxicity of poly(2-(dimethylamino)ethyl methacrylate)/plasmid complexes J. Control Release 49 1997 59 71
35. F.J. Verbaan, C. Oussoren, C.J. Snel, D.J.A. Crommelin, W.E. Hennink, and G. Storm Steric stabilization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice J. Gene Med. 6 2004 64 75
36. S. Beckebaum, V.R. Cicinnati, and G. Gerken DNA-based immunotherapy: potential for treatment of chronic viral hepatitis? Rev. Med. Virol. 12 2002 297 319
37. D. Goula, C. Benoist, S. Mantero, G. Merlo, G. Levi, and B.A. Demeneix Polyethyleneimine-based intravenous delivery of transgenes to mouse lung Gene Ther. 5 1998 1291 1295
38. A. Kichler, M. Chillon, C. Laborgne, O. Danos, and B. Frisch Intranasal gene delivery with a polyethyleneimine-PEG conjugate J. Control Release 81 2002 379 388
39. F.M. Orson, B.M. Kinsey, P.J. Hua, B.S. Bhogal, C.L. Densmore, and M.A. Barry Genetic immunization with lung-targeting macroaggregated polyethyleimine-albumin conjugates elicits combined systemic and mucosal immune responses J. Immunol. 164 2000 6313 6321
40. P. Moingeon Strategies for designing vaccines eliciting Th1 responses in humans J. Biotechnol. 98 2002 189 198
41. R.A. Seder, and AV.S. Hill Vaccines against intracellular infections requiring cellular immunity Nature 17 2000 793 798
42. M.C. Jung, N. Gruner, R. Zachoval, W. Schraut, T. Gerlach, and H. Diepolder Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers Vaccine 20 2002 3598 3612
43. J. Rengarajan, S.J. Szabo, and L.H. Glimcher Transcriptional regulation of Th1/Th2 polarization Immunol. Today 21 2000 479 483